Exercise Exercise

Exercise-based cardiac rehabilitation programs are effective in reducing cardiac deaths and have many positive health-related outcomes including improvements in fitness, symptoms, quality of life, sleep, and reduced feelings of depression and anxiety. [#oka-rk-de-marco-t-haskell-wl-et-al.-2000,#taylor-rs-sagar-va-davies-ej-et-al.-2014] Patients with known disease or those who have had cardiac surgery should be referred to a specifically designed exercise program.

Regular, sustained exercise improves cardiovascular health and slows the progression or partially reduces the severity of coronary atherosclerosis.[#niebauer-j-hambrecht-r-velich-t-et-al.-1997,#haskell-wl-alderman-el-fair-jm-et-al.-1994]

The anti-atherosclerotic effect of exercise is in part brought about by improved endothelial function in response to increased vascular shear stress[#niebauer-j-cooke-jp.-1996,#dimmeler-s-zeiher-am.-2003] and by reduced chronic inflammation, which influences atherosclerotic pathogenesis and plaque stability.[#maseri-a.-1997]

Exercise improves cardiovascular risk factor profiles by:[#leon-as-franklin-ba-costa-f-et-al.-2005]

  • Lowering blood pressure (BP)
  • Lowering low-density lipoprotein cholesterol (LDL-C) levels
  • Increasing high-density lipoprotein cholesterol (HDL-C) levels
  • Lowering serum triglycerides levels
  • Reducing body weight and adiposity
  • Improving insulin sensitivity
  • Improving blood glucose homeostasis.

Participation in habitual exercise not only improves physiological function, but can also enhance psychosocial outcomes.[#thow-m-ed..-2006]

There is strong evidence supporting the benefits of regular physical activity in people with heart failure (HF) and all patients should be referred to a specifically designed physical activity program, if available.[#National-Heart-Foundation-of-Australia-and-the-Cardiac-Society-of-Australia]  Benefits of exercise training include improved quality of life, cardiorespiratory fitness and reduced symptoms of fatigue and dyspnoea. The gold standard measure of aerobic fitness, peak oxygen consumption (VO2peak), is strongly associated with survival in HF patients and typically increases by 15-20% over a training period of 8-12 weeks, with some studies showing increases of up to 30%.[#myers-j-gullestad-l-vagelos-r-et-al.-1998,#pina-il-apstein-cs-balady-gj-et-al.-2003]

These improvements in cardiovascular fitness are predominantly due to peripheral adaptations, such as improved oxidative capacity of skeletal muscle and enhanced peripheral blood flow following aerobic training, and muscle hypertrophy following resistance training.[#crimi-e-ignarro-l-cacciatore-f-et-al.-2009] Resistance training complements aerobic exercise, resulting in strength increases of up to 40%, although outcomes vary substantially depending on the characteristics of the training intervention.[#volaklis-k-tokmakidis-s.-2005]  In 2007, a meta-analysis showed that cardiac dimensions and function could be improved slightly, but only with aerobic exercise rather than resistance exercise.[#haykowsky-m-liang-y-pechter-d-et-al.-2007]

Recent work has raised the possibility that vigorous or high-intensity intermittent exercise may offer superior benefits to HF patients compared with low-to-moderate intensity continuous aerobic training with regard to VO2. This approach should be limited to specialist centres with rapid access to medical support until safety is more definitively established

Psychological benefits of exercise training include reduced depression and anxiety, and improved quality of life.[#oka-rk-de-marco-t-haskell-wl-et-al.-2000,#taylor-rs-sagar-va-davies-ej-et-al.-2014] HF patients who exercise regularly also have better clinical outcomes.[#piepoli-mf-davos-c-francis-dp-et-al.-2004,#smart-n-marwick-th.-2004]  The largest exercise training study in HF, the HF-ACTION trial, randomised 2,331 patients to aerobic exercise or usual care. After adjusting for predetermined prognostic factors, exercise training was associated with a 15% reduction in all-cause mortality and decreased the number of hospitalisations due to HF.[#oconnor-c-whellan-d-lee-k-et-al.-2009]

Is exercise safe for patients with heart failure?

To date, research studies have been conducted predominantly in patients with stable symptoms (New York Heart Association [NYHA] Class I-III) and in young males. In these cohorts, moderate-intensity exercise is well tolerated. There are published data on over 125,000 patient-hours of exercise in clinical studies and, to date, there have not been any deaths directly related to the effects of exercise training in any of these studies.[#chen-ym-li-zb-zhu-m-et-al.-2012] Notably, however, exercising patients have fewer episodes of decompensation and other serious events than those who do not exercise.[#chen-ym-li-zb-zhu-m-et-al.-2012]

The safety of exercise for patients with more severe HF, women, the elderly and those recently discharged from hospital is less conclusive; therefore, exercise for these groups should be prescribed more conservatively. Those with more severe symptoms are most likely to demonstrate greater mortality and morbidity benefit from supervised exercise training compared to those with fewer symptoms.[#piepoli-mf-davos-c-francis-dp-et-al.-2004]  Similarly, those with frailty also benefit from exercise training and should not be excluded from exercise training programs.

Training the periphery is a specific objective of exercise in cardiac patients because the locus of limitation commonly lies in the skeletal muscles.

Exercise prescription is characterised by the following variables, known as the FITT principle:

  • Frequency – the number of times exercise is performed per week
  • Intensity – how hard the exercise is
  • Time (duration) – the total time of an exercise session
  • Type – the mode of exercise

The total amount (dose) of exercise is a function of its intensity, duration and frequency. This total quantity is the main determinant of outcomes. Exercise prescription must consider these variables in combination as they influence both potential training adaptation and the level of fatigue to be expected.

The Fick equation (see below) is used by scientists to identify the various components of oxygen consumption and therefore energy expenditure during physical exertion. The Fick equation can help identify the limitations of physical exertion.

Fick equation

Oxygen consumption (VO2) = Cardiac output (CO) x arteriovenous oxygen difference (a-VO2)

The hallmark of heart failure (HF) is exercise intolerance due to shortness of breath and fatigue. In people with HF, skeletal muscle function is often impaired and may contribute to symptoms that are experienced.

There are several reasons why skeletal muscle dysfunction or atrophy occurs:

  1. Atrophy correlates with the magnitude of skeletal muscle apoptosis.[#agusti-ag-sauleda-j-miralles-c-et-al.-2002] Apoptosis in healthy people is the normal process of replacing old cells with new, but in HF apoptosis becomes dysfunctional and muscle cells are removed prematurely without adequate new cell replacements
  2. As the number of muscle fibres is reduced so is the number of small blood vessels (capillaries) supplying these muscles. In HF, reduced capillarisation is compounded by increased levels of inflammation. The net result is impaired circulation to the already atrophied muscles, which precipitates premature muscle fatigue
  3. Because of atrophy and impaired perfusion and hence oxygen delivery, highly reactive oxygen species are formed during even mild physical exertion. These worsen the already chronic inflammation. This process is known as 'oxidative stress'
  4. Chronic inflammation and oxidative stress lead to biochemical abnormalities. One such example is elevated levels of noradrenaline which leads to an elevated heart rate (HR) and therefore increased cardiac work. This in turn adds to the vicious cycle of creating more oxidative stress, apoptosis, atrophy etc., as shown in the figure below

Figure 1: Development of skeletal muscle dysfunction

Skeletal muscle dysfunction diagram

When prescribing exercise for patients with cardiac disease, it is important to consider the underlying physiology of the cardiac condition. For more detailed information, see exercise for specific clinical conditions.

Ischaemic heart disease

Individuals with ischaemic heart disease, but not HF, can be prescribed longer continuous exercise tasks unless they are limited by angina symptoms. Furthermore, the use of resistance training may be less detrimental to cardiac function in these patients. The presence of co-morbid diseases such as diabetes or chronic obstructive pulmonary disease (COPD), however, may require the exercise intensity and volume to be adjusted according to symptoms and not age expectations.

Heart failure

Exercise intolerance is a hallmark feature of HF with the primary limitation being impaired cardiac output (CO).   A CO of approximately 5 litres per minute is needed to sustain organ function and prevent symptoms of exertion. Healthy people can raise their CO to 15-20 litres per minute during physical stress, however patients with HF, may not be able to increase their CO to the same extent during exertion.

For patients with HF, there is often insufficient blood delivery to working muscles during exercise which is often compounded by a smaller skeletal muscle mass served by a deficient capillary bed. The net result is that the ability of someone with HF to extract oxygen from the blood is impaired. With consideration to the Fick equation, this means that CO is impaired in patients with HF, while the arterial-venous oxygen difference is also abnormally low.

The exercise guidelines for HFrEF and HFpEF are effectively the same, with both groups benefiting to a similar degree from aerobic exercise.  For older and frailer patients, as is commonly the case for those with HFpEF, resistance training may play a more significant role.  In these patients, resistance training aims to improve the active muscle mass available during physical exertion without the risk of compromising systolic function.

Functional class is also relevant when prescribing exercise. Most patients with heart failure symptoms classified as NYHA functional class II and III are able to attend and complete group exercise rehabilitation programs if accessible. However, some patients with class III and IV symptoms may benefit from supported home-based exercise approaches whereby exercises can be tailored to a lower intensity level and progressed more slowly to accommodate the individual’s level of fatigue and function.

  • Oka RK, De Marco T, Haskell WL, et al. Impact of a home-based walking and resistance-training program on quality of life in patients with heart failure. Am J Cardiol 2000;85:365-369.

  • Taylor RS, Sagar VA, Davies EJ, et al. Exercise-based rehabilitation for heart failure. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD003331. DOI: 10.1002/14651858.CD003331.pub4.

  • Niebauer J, Hambrecht R, Velich, T et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation 1997;96:2534-2541.

  • Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Prevention Project (SCRIP). Circulation 1994;89:975-990.

  • Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol 1996;28:1652-1660.

  • Dimmeler S, Zeiher AM. Exercise and cardiovascular health: get active to "AKTivate" your endothelial nitric oxide synthase. Circulation 2003;107:3118-3120.

  • Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 1997;336:1014-1016.

  • Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: An American Heart Association Scientific Statement from the Council on Clinical Cardiology. Circulation 2005;111:369-376.

  • Thow M (Ed.). Exercise Leadership in Cardiac Rehabilitation - An evidence-based approach. UK: John Wiley & Sons Ltd. 2006.

  • NHFA CSANZ Heart Failure Guidelines Working Group: Atherton JJ, Sindone A, De Pasquale CG, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart Lung Circ. 2018;27(10):1123-208.

  • Myers J, Gullestad L, Vagelos R, et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 1998;129:286-293.

  • Pina IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: A statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention. Circulation 2003;107:1210-1225.

  • Crimi E, Ignarro L, Cacciatore F, et al. Mechanisms by which exercise training benefits patients with heart failure. Nat Rev Cardiol 2009;6:292-300.

  • Volaklis K, Tokmakidis S. Resistance exercise training in patients with heart failure. Sports Med 2005;35:1085-1103.

  • Haykowsky M, Liang Y, Pechter D, et al. A meta-analysis of the effect of exercise training on left ventricular remodelling in heart failure patients: The benefit depends on the type of training performed. J Am Coll Cardiol 2007;49:2329-2336.

  • Piepoli MF, Davos C, Francis DP, et al. ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004;328:189. 

  • Smart N, Marwick TH. Exercise training for patients with heart failure: A systematic review of factors that improve mortality and morbidity. Am J Med 2004;116:693-706.

  • O'Connor C, Whellan D, Lee K, et al. HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomised controlled trial. JAMA 2009;301:1439-1450.

  • Chen YM, Li ZB, Zhu M et al. Effects of exercise training on left ventricular remodelling in heart failure patients: an updated meta-analysis of randomised controlled trials. Int J Clin Pract 2012;66:782-791.

  • Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:485-489.